RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Financials
  4. Cash from financing

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$364.6M
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 202457+7.63%
Dec 31, 202353+25.71%
Dec 31, 202242-12.81%
Dec 31, 202148-8.66%
Dec 31, 202053+429.50%
Dec 31, 201910+26.44%
Dec 31, 20188-77.05%
Dec 31, 201734-10.49%
Dec 31, 201638-59.35%
Dec 31, 201594+9.81%
Dec 31, 201486-56.77%
Dec 31, 2013199+32.73%
Dec 31, 2012150+25.24%
Dec 31, 2011119

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)